{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:50:11Z","timestamp":1791661811211,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pathol.2026.07.011","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:06:13Z","timestamp":1789085173000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical utility and healthcare cost of antinuclear antibody testing in inpatients at a major tertiary hospital"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5938-0292","authenticated-orcid":false,"given":"Paul Sun Woo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-6298","authenticated-orcid":false,"given":"Stephen","family":"Adelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8395-4365","authenticated-orcid":false,"given":"Alex","family":"Stoyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2026.07.011_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5858\/2000-124-0071-GFCUOT","article-title":"Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens","volume":"124","author":"Kavanaugh","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2026.07.011_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.autrev.2015.10.007","article-title":"Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years","volume":"15","author":"Selmi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pathol.2026.07.011_bib3","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pathol.2026.07.011_bib4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/ped.14592","article-title":"Anti-nuclear antibody testing in children: how much is really necessary?","volume":"63","author":"Haslak","year":"2021","journal-title":"Pediatr Int"},{"key":"10.1016\/j.pathol.2026.07.011_bib5","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e159","article-title":"Diagnostic value of anti-nuclear antibodies: results from Korean university-affiliated hospitals","volume":"37","author":"Kang","year":"2022","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.pathol.2026.07.011_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.amjmed.2012.09.014","article-title":"The clinical utility of a positive antinuclear antibody test result","volume":"126","author":"Abeles","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.pathol.2026.07.011_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jclinpath-2015-202970","article-title":"Evaluation of antinuclear antibody (ANA) in ANA-associated connective tissue diseases","volume":"68","author":"Lee","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.pathol.2026.07.011_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.12669\/pjms.302.4276","article-title":"Determination of anti-nuclear antibody pattern distribution and clinical relationship","volume":"30","author":"Mengeloglu","year":"2014","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.pathol.2026.07.011_bib9","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1996.00440120079007","article-title":"Antinuclear antibody testing: a study of clinical utility","volume":"156","author":"Slater","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pathol.2026.07.011_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093812","article-title":"Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies","volume":"9","author":"Fitch-Rogalsky","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2026.07.011_bib11","first-page":"150","article-title":"Association between antinuclear antibodies titers and connective tissue diseases in a rheumatology department","volume":"13","author":"Almagro","year":"2017","journal-title":"Rheumatol Clin"},{"key":"10.1016\/j.pathol.2026.07.011_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005288","article-title":"Is it relevant to screen young women hospitalized in psychiatric department for neuropsychiatric systemic lupus erythematosus (NPSLE)?: a prospective study of 100 psychiatric inpatients","volume":"95","author":"Audemard-Verger","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pathol.2026.07.011_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9343(91)80089-5","article-title":"Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study","volume":"90","author":"Olsen","year":"1991","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"10.1016\/j.pathol.2026.07.011_bib14","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.2025-0314.TOUR3A","article-title":"Value and appropriateness of inpatient antinuclear antibody testing at a tertiary hospital","volume":"52","author":"Udupa","year":"2025","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pathol.2026.07.011_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/acr.21930","article-title":"Choosing wisely: the American College of Rheumatology's top 5 list of things physicians and patients should question","volume":"65","author":"Yazdany","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.pathol.2026.07.011_bib16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3899\/jrheum.141140","article-title":"Choosing wisely: the Canadian Rheumatology Association\u2019s list of 5 items physicians and patients should question","volume":"42","author":"Chow","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pathol.2026.07.011_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/000456329903600209","article-title":"Different strategies in the laboratory diagnosis of autoimmune disease: immunofluorescence, enzyme-linked immunosorbent assay or both?","volume":"36","author":"Rondeel","year":"1999","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.pathol.2026.07.011_bib18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.pathol.2016.06.003","article-title":"The concordance of serial ANA tests in an Australian tertiary hospital pathology laboratory","volume":"48","author":"Lee","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2026.07.011_bib19","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1016\/S2665-9913(20)30084-9","article-title":"Utility of repeated antinuclear antibody tests: a retrospective database study","volume":"2","author":"Yeo","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.pathol.2026.07.011_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jcp.2004.021691","article-title":"Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory","volume":"58","author":"Kwok","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.pathol.2026.07.011_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10067-012-2141-y","article-title":"An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing","volume":"32","author":"Man","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.pathol.2026.07.011_bib22","article-title":"Inappropriate use of commercial antinuclear antibody testing in a community-based US hospital: a retrospective study","volume":"6","author":"Mohammed","year":"2016","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.pathol.2026.07.011_bib23","series-title":"Medicare Benefits Schedule Book operating from","year":"2022"},{"key":"10.1016\/j.pathol.2026.07.011_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.pathol.2026.07.011_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap Consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.pathol.2026.07.011_bib26","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1007\/s00431-023-05017-w","article-title":"Clinical usefulness of anti-nuclear antibody in childhood: real-world experience at a tertiary care center: usefulness of ANA in pediatric autoimmune diseases","volume":"182","author":"\u015eahin","year":"2023","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pathol.2026.07.011_bib27","first-page":"4","article-title":"Prevalence and disease associations of certain autoantibodies in elderly patients","volume":"21","author":"Juby","year":"1998","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.pathol.2026.07.011_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.06.006","article-title":"Cellular aging over 13 years associated with incident antinuclear antibody positivity in the Baltimore Longitudinal Study of Aging","volume":"105","author":"Meier","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.pathol.2026.07.011_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2011.03.020","article-title":"Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort","volume":"56","author":"Armstrong","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.pathol.2026.07.011_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003099","article-title":"What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study","volume":"3","author":"Lilford","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.pathol.2026.07.011_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","article-title":"Guidelines on the management of abnormal liver blood tests","volume":"67","author":"Newsome","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.pathol.2026.07.011_bib32","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(97)08140-3","article-title":"Value of assessment of pretest probability of deep-vein thrombosis in clinical management","volume":"350","author":"Wells","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2026.07.011_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1742-6723.13125","article-title":"Effect of a clinical flowchart incorporating Wells score, PERC rule and age-adjusted D-dimer on pulmonary embolism diagnosis, scan rates and diagnostic yield","volume":"31","author":"Buntine","year":"2019","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.pathol.2026.07.011_bib34","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1007\/s10067-024-07180-3","article-title":"Mitigating overuse of antinuclear antibody (ANA) testing through educational intervention: a study in internal medicine and neurology departments","volume":"43","author":"Pri-Paz Basson","year":"2024","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.pathol.2026.07.011_bib35","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s10067-021-05594-x","article-title":"The impact of education and clinical decision support on the quality of positive antinuclear antibody referrals","volume":"40","author":"Patel","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.pathol.2026.07.011_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201552","article-title":"Health services costs for cancer care in Australia: estimates from the 45 and Up Study","volume":"13","author":"Goldsbury","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2026.07.011_bib37","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/acr.24990","article-title":"Frequency and clinical utility of antibodies to extractable nuclear antigen in the setting of a negative antinuclear antibody test","volume":"75","author":"Yeo","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526006410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526006410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:26:06Z","timestamp":1791660366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302526006410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S0031302526006410"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2026.07.011","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical utility and healthcare cost of antinuclear antibody testing in inpatients at a major tertiary hospital","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2026.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}